Henry Schein, Inc. (NASDAQ:HSIC) Director Philip A. Laskawy Sells 2,604 Shares

Henry Schein, Inc. (NASDAQ:HSIC) Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total value of $184,988.16. Following the completion of the sale, the director now directly owns 24,805 shares of the company’s stock, valued at approximately $1,762,147.20. This represents a 9.50 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

Henry Schein Stock Performance

Shares of NASDAQ HSIC opened at $69.39 on Friday. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. The firm has a market cap of $8.62 billion, a price-to-earnings ratio of 28.56, a P/E/G ratio of 2.13 and a beta of 0.90. The business’s 50-day simple moving average is $74.82 and its 200-day simple moving average is $72.61. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.49.

Henry Schein (NASDAQ:HSIC) last issued its quarterly earnings data on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). The company had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business’s revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the company posted $0.66 EPS. As a group, equities research analysts expect that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Institutional Trading of Henry Schein

Hedge funds have recently added to or reduced their stakes in the business. Nuance Investments LLC boosted its stake in Henry Schein by 22.3% during the 3rd quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock valued at $166,072,000 after purchasing an additional 414,748 shares during the period. Olstein Capital Management L.P. boosted its stake in Henry Schein by 17.2% during the 4th quarter. Olstein Capital Management L.P. now owns 109,000 shares of the company’s stock valued at $7,543,000 after purchasing an additional 16,000 shares during the period. B. Metzler seel. Sohn & Co. Holding AG bought a new stake in Henry Schein during the 3rd quarter valued at approximately $515,000. Private Management Group Inc. boosted its stake in Henry Schein by 5.7% during the 4th quarter. Private Management Group Inc. now owns 350,515 shares of the company’s stock valued at $24,256,000 after purchasing an additional 18,882 shares during the period. Finally, Equitable Trust Co. bought a new stake in Henry Schein during the 4th quarter valued at approximately $417,000. Institutional investors own 96.62% of the company’s stock.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the company. Barrington Research reissued an “outperform” rating and issued a $90.00 price objective on shares of Henry Schein in a research note on Wednesday, February 26th. Wells Fargo & Company began coverage on Henry Schein in a research note on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price objective for the company. Bank of America raised Henry Schein from an “underperform” rating to a “buy” rating and upped their target price for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. UBS Group dropped their target price on Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 26th. Finally, Jefferies Financial Group upped their target price on Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a research report on Thursday, January 23rd. Six equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $81.10.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.